Biosenta Inc.
ZRO
CNSX
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -346.30K | -3.90M | -368.10K | -249.00K | -178.20K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 93.60K | 3.57M | 104.40K | 9.60K | 11.30K |
| Change in Net Operating Assets | -2.90K | 232.90K | 141.50K | 178.60K | 34.20K |
| Cash from Operations | -255.60K | -92.80K | -122.20K | -60.80K | -132.70K |
| Capital Expenditure | -- | -11.60K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -11.60K | -- | -- | -- |
| Total Debt Issued | 500.00 | 117.60K | 184.60K | 68.80K | 174.00K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 500.00K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -14.00K | -- | -- | -- | -- |
| Cash from Financing | 357.60K | 87.60K | 137.40K | 50.90K | 128.20K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 102.00K | -16.70K | 15.30K | -9.90K | -4.50K |
